Truist Financial Corp Repligen Corp Transaction History

Truist Financial Corp

  • $62.7 Billion
  • Q4 2024

A detailed history of Truist Financial Corp transactions in Repligen Corp stock. As of the latest transaction made, Truist Financial Corp holds 2,953 shares of RGEN stock, worth $433,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,953
Previous 3,331 11.35%
Holding current value
$433,854
Previous $495,000 14.14%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
SELL
$123.41 - $160.92 $46,648 - $60,827
-378 Reduced 11.35%
2,953 $425,000
Q3 2024

Nov 13, 2024
BUY
$119.79 - $167.35 $79,540 - $111,120
664 Added 24.9%
3,331 $495,000
Q2 2024

Aug 20, 2024
SELL
$120.0 - $182.95 $81,600 - $124,405
-680 Reduced 20.32%
2,667 $336,000
Q1 2024

May 10, 2024
SELL
$170.78 - $208.42 $154,214 - $188,203
-903 Reduced 21.25%
3,347 $615,000
Q4 2023

Feb 02, 2024
BUY
$114.17 - $185.35 $61,423 - $99,718
538 Added 14.49%
4,250 $764,000
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $41,634 - $52,953
300 Added 8.79%
3,712 $590,000
Q2 2023

Aug 01, 2023
BUY
$138.42 - $180.31 $79,729 - $103,858
576 Added 20.31%
3,412 $482,000
Q1 2023

May 05, 2023
SELL
$154.26 - $198.1 $308,057 - $395,605
-1,997 Reduced 41.32%
2,836 $477,000
Q4 2022

Feb 17, 2023
SELL
$162.42 - $220.56 $58,796 - $79,842
-362 Reduced 6.97%
4,833 $818,000
Q3 2022

Oct 26, 2022
SELL
$160.42 - $256.21 $27,431 - $43,811
-171 Reduced 3.19%
5,195 $972,000
Q2 2022

Jul 22, 2022
SELL
$140.68 - $188.02 $36,014 - $48,133
-256 Reduced 4.55%
5,366 $871,000
Q1 2022

Apr 22, 2022
SELL
$161.19 - $257.96 $202,454 - $323,997
-1,256 Reduced 18.26%
5,622 $1.06 Million
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $116,119 - $142,796
-469 Reduced 6.38%
6,878 $1.82 Million
Q3 2021

Nov 05, 2021
BUY
$194.77 - $324.21 $260,212 - $433,144
1,336 Added 22.23%
7,347 $2.12 Million
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $94,048 - $125,278
567 Added 10.42%
6,011 $1.2 Million
Q1 2021

May 17, 2021
BUY
$180.37 - $226.26 $27,416 - $34,391
152 Added 2.87%
5,444 $1.06 Million
Q4 2020

Nov 19, 2021
SELL
$148.08 - $206.57 $279,426 - $389,797
-1,887 Reduced 26.28%
5,292 $1.01 Million
Q4 2020

Feb 18, 2021
BUY
$148.08 - $206.57 $386,340 - $538,941
2,609 Added 57.09%
7,179 $1.38 Million
Q3 2020

Nov 13, 2020
SELL
$122.51 - $158.27 $38,590 - $49,855
-315 Reduced 6.45%
4,570 $675,000
Q2 2020

Aug 14, 2020
SELL
$94.33 - $140.48 $72,539 - $108,029
-769 Reduced 13.6%
4,885 $605,000
Q1 2020

May 15, 2020
SELL
$84.96 - $109.14 $24,213 - $31,104
-285 Reduced 4.8%
5,654 $546,000
Q4 2019

Feb 14, 2020
BUY
$73.84 - $93.08 $81,076 - $102,201
1,098 Added 22.68%
5,939 $549,000
Q3 2019

Oct 31, 2019
SELL
$76.65 - $95.51 $119,880 - $149,377
-1,564 Reduced 24.42%
4,841 $372,000
Q2 2019

Jul 24, 2019
SELL
$54.2 - $85.95 $13,821 - $21,917
-255 Reduced 3.83%
6,405 $550,000
Q1 2019

Apr 23, 2019
BUY
$49.45 - $62.8 $3,708 - $4,710
75 Added 1.14%
6,660 $393,000
Q4 2018

Jan 22, 2019
SELL
$48.26 - $68.88 $28,232 - $40,294
-585 Reduced 8.16%
6,585 $347,000
Q3 2018

Oct 17, 2018
SELL
$46.8 - $58.97 $19,422 - $24,472
-415 Reduced 5.47%
7,170 $398,000
Q2 2018

Jul 26, 2018
SELL
$35.26 - $47.04 $13,398 - $17,875
-380 Reduced 4.77%
7,585 $357,000
Q1 2018

Apr 20, 2018
BUY
$30.92 - $37.27 $3,710 - $4,472
120 Added 1.53%
7,965 $288,000
Q4 2017

Jan 29, 2018
SELL
$32.53 - $38.92 $975 - $1,167
-30 Reduced 0.38%
7,845 $285,000
Q3 2017

Oct 23, 2017
BUY
$36.98 - $46.06 $291,217 - $362,722
7,875
7,875 $302,000

Others Institutions Holding RGEN

# of Institutions
479
Shares Held
54.9M
Call Options Held
297K
Put Options Held
343K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email